SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-166745
Filing Date
2011-06-16
Accepted
2011-06-16 17:05:31
Documents
4
Period of Report
2011-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K d8k.htm 8-K 43554
2 AVI BIOPHARMA, INC. 2011 EQUITY INCENTIVE PLAN dex101.htm EX-10.1 107078
3 FORM OF STOCK OPTION AWARD AGREEMENT UNDER THE 2011 EQUITY INCENTIVE PLAN dex102.htm EX-10.2 44555
4 FORM OF NOTICE OF GRANT OF RESTRICTED STOCK UNDER THE 2011 EQUITY INCENTIVE PLAN dex103.htm EX-10.3 34661
  Complete submission text file 0001193125-11-166745.txt   231246
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 11915847
SIC: 2834 Pharmaceutical Preparations